相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Optimal management of elderly patients with glioblastoma
Normand Laperriere et al.
CANCER TREATMENT REVIEWS (2013)
A pilot study of glioblastoma multiforme in elderly patients: Treatments, O-6-methylguanine-DNA methyltransferase (MGMT) methylation status and survival
K. Abhinav et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2013)
The treatment of glioblastomas: A systematic update on clinical Phase III trials
An-an Yin et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Radiotherapy Plus Concurrent or Sequential Temozolomide for Glioblastoma in the Elderly: A Meta-Analysis
An-an Yin et al.
PLOS ONE (2013)
Clinical neuropathology practice guide 06-2012: MGMT testing in elderly glioblastoma patients - yes, but how?
Anna S. Berghoff et al.
CLINICAL NEUROPATHOLOGY (2012)
Predictive impact of MGMT promoter methylation in glioblastoma of the elderly
Guido Reifenberger et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Phase II Study of Short-Course Radiotherapy Plus Concomitant and Adjuvant Temozolomide in Elderly Patients With Glioblastoma
Giuseppe Minniti et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
Annika Malmstrom et al.
LANCET ONCOLOGY (2012)
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
Wolfgang Wick et al.
LANCET ONCOLOGY (2012)
Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice
Michael Weller et al.
NEURO-ONCOLOGY (2012)
Prognostic Value of Three Different Methods of MGMT Promoter Methylation Analysis in a Prospective Trial on Newly Diagnosed Glioblastoma
Arne Christians et al.
PLOS ONE (2012)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
Douglas G. Altman et al.
PLOS MEDICINE (2012)
Review and Metaanalysis of the Frequency of Familial Dilated Cardiomyopathy
Mario Petretta et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Temozolomide in Elderly Patients With Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial
Jaime Gallego Perez-Larraya et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Prognostic or Predictive? It's Time to Get Back to Definitions!
Antoine Italiano
JOURNAL OF CLINICAL ONCOLOGY (2011)
Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomide
Giuseppe Minniti et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
CHEMORADIOTHERAPY OF NEWLY DIAGNOSED GLIOBLASTOMA WITH INTENSIFIED TEMOZOLOMIDE
Markus Weiler et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
Michael Weller et al.
NATURE REVIEWS NEUROLOGY (2010)
Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy
J. Dunn et al.
BRITISH JOURNAL OF CANCER (2009)
Temozolomide Concomitant and Adjuvant to Radiotherapy in Elderly Patients With Glioblastoma Correlation With MGMT Promoter Methylation Status
Alba A. Brandes et al.
CANCER (2009)
Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network
Michael Weller et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Age as a Predictive Factor in Glioblastomas: Population-Based Study
Daisuke Kita et al.
NEUROEPIDEMIOLOGY (2009)
MGMT METHYLATION IS A PROGNOSTIC BIOMARKER IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
E. R. Gerstner et al.
NEUROLOGY (2009)
Patterns of Care in Elderly Glioblastoma Patients
Fabio M. Iwamoto et al.
ANNALS OF NEUROLOGY (2008)
Validation of real-time methylation-specific PCR to determine O6-methylguanine-DNA methyltransferase gene promoter methylation in glioma
Ilse Vlassenbroeck et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme
Angelique E. Sijben et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma:: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO)
A. A. Brandes et al.
BRITISH JOURNAL OF CANCER (2006)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)